• Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
  • Rss
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • State of Survivorship Survey
      • 2022 Survey
      • 2021 Survey
      • 2020 Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Advocate Engagement Opportunities
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Cancer Rehabilitation
    • Integrative Oncology
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Telehealth
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • 2022 Winners
      • Awardees
      • Reception and Sponsorship
      • Committees
      • Nominations
    • Cancer Policy Roundtable (CPR)
      • Fall 2022 CPR
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Your generous year-end donation will be matched $1 for $1    DONATE

Zanartu Help Hurt Tool Physician

Guest Blog: Improving How Doctors and Patients Have Difficult Conversations

July 13, 2016/in Cancer News, Cancer Policy Blog Care Planning, Palliative Care, Quality Cancer Care, Shared Decision-Making, Survivorship Care NCCS News
Cristian Zanartu, MD

Post by Cristian Zanartu, MD
Montefiore Einstein Center for Cancer Care
Bronx, NY

Having cancer is terrifying. Period. Often, well-intended doctors find themselves unable to mitigate this panic.

As humans we are challenged with this disease as old as our chromosomes, struck at the core of our identity, of our body, of our sense of self. We are removed from work, from a normal agenda, from our families, from our mirrors. We learn to fight with something inside of us. We learn to split ourselves apart.

However, there is one part of ourselves that can always be preserved, always untouched, always whole: our dignity. Time and again studies show that dignity—defined in a multiplicity of ways—is one of the main elements that help patients cope with serious or advanced disease. Dignity has been linked to quality of life, symptom control, and even survival. Dignity can help patients engage to surmount challenges, like days filled with hours of chemotherapy. Dignity can help confront news when they are not as expected. Dignity can be the distinguished silence with which patients assertively prepare for their passing, and become examples of bravery and acceptance for their loved ones.

As a palliative medicine specialist, I see that one of the main hazards for patients’ dignity is lack of communication. Well-intended families and doctors protect patients from real discussions about what to expect from their treatments. This is particularly frequent of those cancers with poor prognosis and when therapies with only limited benefit are being offered.

“Don’t patients deserve to know these expectations? Should we leave the knowledge that allows us to know what to expect only at the doctor’s side of the table, and leave patients always in the unexpected?”
To have a voice in one’s care, one needs to be aware. Medicine has shifted from a paternalistic model to one of shared decision-making. The way we transmit information in cancer has to change in this direction as well. Studies have shown that the majority of patients undergoing serious chemotherapy treatments for diseases as complicated as advanced lung or colon cancer do not understand what is the goal of these drugs. Receiving 4-hour infusion 3-drug cocktails with an intention to cure versus an intention to halt disease for some time are two very different scenarios, which will weigh differently for a patient against serious side effects. With an ever-changing field such as oncology, and with doctors rushing to keep up with new and exciting options for patients, the complexities are immense; trying to deliver nuanced and delicate information about treatment options to patients, while the pressured clock of the doctor’s office and the often unjust clock of the patient’s time are both ticking.

The Help-Hurt Tool

The Help-Hurt Tool Demo

Dr. Zanartu Demonstrates the Help-Hurt Tool (click to expand)

The Help-Hurt tool (helphurttool.com) was created by palliative care physicians and oncologists at the Montefiore Einstein Cancer Center as a way of bringing accessible and transparent information inside the doctor’s office when a new therapy is being presented. Although initially thought for cancer, we believe it can be used for any serious disease for which a treatment plan is being discussed.

The logic behind this tool is quite simple: every single treatment in medicine—whether it be an over-the-counter tablet of 100 milligrams of aspirin or open-heart surgery—possesses a potential benefit and a potential risk. Cancer treatments of course don’t escape this.

In regards to benefit, some cancer treatments provide promise of cure—like chemotherapy regimens for many malignancies originating from blood cells or for initial stages of some organ cancers. On the other hand, some cancer treatments offer only some more time of survival without growth of the disease, therefore extending life and improving symptoms, but not a cure. This time can be estimated in years, months or, sadly, just in weeks. And in some instances, a cancer treatment is just a desperate attempt at “trying something else,” either at the persistence of patient and family, as a source for hope or as an understandable—yet not frequently justified—need for a doctor to send his patient a message of non-abandonment.

Read the Companion Post

Zanartu Help Hurt Tool Physician

Guest Blog: Example of a Case Impacted by the Help-Hurt Tool

Ms. M is an 81-year-old woman with Stage IV Pancreatic Cancer. She had remained in great health until her recent diagnosis, after which her energy had plummeted…

The ways cancer treatments can harm also vary significantly. For instance, drugs like hormonal blocking agents seldom produce dangerous side effects. On the other hand, chemotherapy infusion drugs like Cisplatin can be difficult to tolerate and lead to more side effects. Generally a patient that is older and/or has more medical issues will tolerate these drugs worse than a healthy/young patient.

We do not possess absolutes in prognostication in medicine. We can never be sure how much a therapy will help or hurt a patient. Every so often a frail patient can make a fantastic recovery from an aggressive intervention, and on the other end, a healthy patient dies from the unexpected complication of an otherwise low risk procedure.

But these are of course not the most likely scenarios. In medicine we often know what will be the most likely scenarios, we can talk on averages, a.k.a. the most likely result of a treatment or intervention. But regardless of information being imperfect, don’t patients deserve to know these expectations? Should we leave the knowledge that allows us to know what to expect only at the doctor’s side of the table, and leave patients always in the unexpected? The answer that this proposed tool gives to this question is: no.

How the Tool Works

Clinical experience gives doctors the capacity to formulate a judgment. This judgment is usually the result of adding the information provided by evidence-based medicine regarding the usual result of a treatment plus the patient’s known circumstances (old vs. young, frail vs. strong, healthy vs. sick). The Help-Hurt tool offers doctors a chance to express this opinion to their patients. This way patients can become better decision makers, importing the physician’s realistic clinical judgment in a useful way.

The Help-Hurt Tool

The Zanartu Help-Hurt tool, courtesy of Montefiore Medical Center (click to view full-size)

Let’s look at the tool. As you can see, the tool has two scales. The first one in blue: “how much could this therapy help me?” rates from 1 through 5 the positive outcomes to be expected from a therapy. The higher the score, the more beneficial a treatment is expected to be. A score of 1 represents a “last resort” therapy, a very small chance it could help you feel better. A score of 2 represents a therapy with a small chance of making you feel better OR with a chance of helping you live weeks longer compared to without it. A score of 3 represents a therapy with a big chance of making you feel better OR with a chance of helping you live months longer compared to without it. A score of 4 represents a therapy with a big chance of helping you live one year or longer compared to without it. A score of 5 is for a therapy that could cure a disease forever. As you can see, between being offered a therapy with a score of 1 or 2 versus one with a score of 5, there is a world of difference. How much burden would you expose yourself to depending on being offered a therapy on one or on the other end of the help spectrum?

The second scale offers the same logic for expected harms of a therapy, in red. How much could this therapy hurt me? The higher the score, the more harmful the treatment could be. A score of 1 represents a therapy with usually no side effects. A score of 2 represents a therapy with non-dangerous side effects like nausea, hair loss, acne/rash, or headaches. A score of 3 represents a therapy with a small chance of serious side effects like infection, damage to other organs, or other complications requiring hospitalization. A score of 4 represents a big chance of the same serious complications. Finally, a score of 5 represents a therapy that could likely be lethal or life threatening itself.

As you can see, every single possible outcome written on the tool is expressed in chances or probabilities. Again, your doctor will never be absolutely sure of how a treatment will help you or hurt you, but these are the most likely scenarios. By knowing them, a patient can make a better informed-decision.

On the bottom of both scales there are arrows that can be moved over to particular help and hurt scores. That way a particular therapy on a particular patient is given the expected scores on both the help and the hurt scales. If different therapy options are on the horizon, a set of help and hurt scores are given for each therapy. For example, therapy A has a help of 3, but a hurt of 4. Meanwhile, therapy B has a help of 4, but a hurt of 5. Ideally, therapies would have a high help score and a low hurt score. However, that is not always possible in medicine today. Often, as diseases get worse and patients sicker, the help score becomes smaller and the hurt score higher.

Incorporating such reality into the conversation is hard, for both patient and doctor. When confronted with cancer, patients need the comfort of being told things are going to be okay. And okay usually means getting rid of disease. Doctors feel the need to give that message. The expectation is for medicine to make a big difference, to save the day, to save a life. Hopefully this tool will be there to display high help scores and low hurt scores when likely successful plans are being offered. But when this is not case: how can doctors be comfortable saying: “this therapy will help you marginally, this other will help you little, this one might just hurt you a lot.” Doesn’t seem like this is what doctors were trained to say. How do we keep hope while giving realistic information?

The answer to these questions opens a whole other can of worms, one this article is unlikely to resolve. How can we re-frame hope when people don’t get better? Have you ever been to an ICU ward? It has a lot of reality, often times little hope. Can we build a hope that transcends old and young, sick and healthy, death and alive? Can we dare to believe in a hope about who we are? About what we are truly worth? About what we truly mean to the others we have met and loved? When hopes of achieving a cure are lost… can we hope to remain ourselves through the challenge, to keep our light on, to rise to the occasion with a body hurt by disease but a dignity intact?


About the Author
Cristian Zanartu, M.D.—a palliative medicine specialist at Montefiore Einstein Center for Cancer Care—treats patients at all stages of their disease, providing continuous support and care to help relieve their physical and emotional symptoms, while guiding them and their loved ones as they face complex choices and decisions.

Dr. Zanartu’s full bio can be read on the Montefiore Cancer Center’s website.

Read more about the Help-Hurt Tool at www.helphurttool.com.


The views & opinions expressed in any guest post featured on our site are those of the guest author and do not necessarily reflect the opinions & views of the National Coalition for Cancer Survivorship. Read our blog and comment policies here.

Tags: cancer care, Cancer Survivorship, Decision-Making, Guest Post, Palliative Care, patient first, patient tools, quality, Shared-decision making
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
https://canceradvocacy.org/wp-content/uploads/2016/07/Zanartu-Help-Hurt-Tool-Physician.jpg 783 1168 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2016-07-13 11:49:092016-07-13 11:49:09Guest Blog: Improving How Doctors and Patients Have Difficult Conversations

Latest News

Webinar – Survivorship at Atrium Health Wake Forest Baptist Comprehensive Cancer Center: Creating a Practical Workflow

May 12, 2023
The National Coalition for Cancer Survivorship (NCCS) hosted a Survivorship Champions webinar about survivorship care implementation,…
Read more
https://canceradvocacy.org/wp-content/uploads/Atrium-Health-Wake-Forest-Baptist-update-POST.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-05-12 12:42:192023-05-12 21:48:11Webinar – Survivorship at Atrium Health Wake Forest Baptist Comprehensive Cancer Center: Creating a Practical Workflow

Sandra Finestone, PsyD: Be Bold and Don’t Hesitate – A 30-year Survivor’s Advice on Advocacy

May 8, 2023
Advocate Spotlight: Sandra Finestone, PsyD A cancer diagnosis can be overwhelming and life-changing, but for Sandra Finestone, it…
Read more
https://canceradvocacy.org/wp-content/uploads/Sandra-Finestone-Advocate-Spotlight-Blog-Banner.png 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-05-08 13:42:472023-05-11 10:49:23Sandra Finestone, PsyD: Be Bold and Don’t Hesitate – A 30-year Survivor’s Advice on Advocacy

Accessing COVID-19 Resources After the Public Health Emergency Ends

May 4, 2023
The COVID-19 public health emergency (PHE), which has been in effect since early 2020, will end on May 11, 2023. The federal government…
Read more
https://canceradvocacy.org/wp-content/uploads/Blog-Webpage-Banner-3.png 600 1200 Kara Kenan https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png Kara Kenan2023-05-04 17:52:452023-05-04 17:52:45Accessing COVID-19 Resources After the Public Health Emergency Ends

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.

  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • State of Survivorship Survey
      • 2022 Survey
      • 2021 Survey
      • 2020 Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Advocate Engagement Opportunities
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Cancer Rehabilitation
    • Integrative Oncology
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Telehealth
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • 2022 Winners
      • Awardees
      • Reception and Sponsorship
      • Committees
      • Nominations
    • Cancer Policy Roundtable (CPR)
      • Fall 2022 CPR
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2023 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

NCCS Comments on Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)...Fotolia 23428619 S e1461260836640Zanartu Help Hurt Tool PhysicianGuest Blog: Example of a Case Impacted by the Help-Hurt Tool
Scroll to top
Download the Survey Report

"*" indicates required fields

Fill out the form below, and we’ll send the survey report, detailed presentation, and infographic to your email.
Name*
I am a...*
Select any/all that apply.
Consent*
By downloading the survey materials, you will receive updates and information from NCCS via email, which you may unsubscribe from at any time. Your information will never be sold to any third parties.
This field is for validation purposes and should be left unchanged.

Get Updates From NCCS

Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.

  • This field is for validation purposes and should be left unchanged.

Connect With Us

Twitter     Facebook     Instagram     LinkedIn     YouTube

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute